Back to top

Image: Bigstock

Options Traders Expect Huge Moves in Intra-Cellular Therapies (ITCI) Stock

Read MoreHide Full Article

Investors in Intra-Cellular Therapies, Inc. (ITCI - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 20, 2019 $12.50 Call had some of the highest implied volatility of all equity options today.

What is Implied Volatility?

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

What do the Analysts Think?

Clearly, options traders are pricing in a big move for Intra-Cellular Therapies shares, but what is the fundamental picture for the company? Currently, Intra-Cellular Therapies is a Zacks Rank #2 (Buy) in the Medical - Biomedical and Genetics industry that ranks in the Top 23% of our Zacks Industry Rank. Over the last 30 days, three analysts have increased the earnings estimates for the current quarter, while none have dropped their estimates. The net effect has taken our Zacks Consensus Estimate for the current quarter has from a loss of $1.23 per share to a loss of 91 cents in that period.

Given the way analysts feel about Intra-Cellular Therapies right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.

Looking to Trade Options?

Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. In addition to impressive profit potential, these trades can actually reduce your risk.

Click to see the trades now >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

IntraCellular Therapies Inc. (ITCI) - free report >>